BACTIVAX

Developing effective vaccines against challenging antimicrobial resistant bacterial infections



 
Image by skeeze from Pixabay.jpg
 
 

Mission

BactiVax (anti-Bacterial Innovative Vaccines) is a European Training Network funded by the European Commission under the Marie Skłodowska-Curie Actions. BactiVax will provide high-level training in vaccinology to a new generation of 15 high-achieving, early-stage researchers. The programme brings together 14 world-class experts in vaccinology from 8 European countries to investigate complementary facets of vaccine research and development. The common goal of BactiVax is to develop effective vaccines against challenging antimicrobial-resistant bacterial infections. For more details about our research and aims see here.

 

 

PROJECT FACTS

 

Grant agreement number 860325


48 months duration


14 Principal Investigators


12 Beneficiaries

€4,009,373 EU contribution


Start date 1 October 2019


15 Early Stage Researchers


9 Countries

 
 
Network background for statistics image (14 PIs, 9 countries, etc).png
 
 

Members

BactiVax brings together a multidisciplinary team of 12 beneficiaries and 7 partners from 9 different countries

BENEFICIARIES

 

PARTNERS

 
 
 

News and Events

 
backround.jpg